Home › Cystic Fibrosis › Kansas
Cystic Fibrosis clinical trials in Kansas
14 studies for Cystic Fibrosis are looking for participants at sites in Kansas.
Cities in Kansas
Phase 2 Study to Assess the Safety and Efficacy of ANG003
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07450547Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
- Altasciences - Kansas City, Overland Park
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Sep 21, 2026 · NCT07283770Sinus Disease in Young Children With Cystic Fibrosis
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 2 to 8 · All sexes · Updated Sep 10, 2026 · NCT06191640Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Up to age 10 · All sexes · Updated Jul 8, 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- University of Kansas Medical Center, Kansas City
RecruitingPhase 4
Ages 6 and older · All sexes · Updated Jul 8, 2026 · NCT055482834D-710 in Adult Patients With Cystic Fibrosis
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT05248230Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Jul 1, 2026 · NCT06985225Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1Healthy volunteers welcome
Ages 3 and older · All sexes · Updated May 6, 2026 · NCT04624490Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT04530383Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- Kansas University Medical Center, Kansas City
RecruitingObservational study
Ages 6 and older · All sexes · Updated Nov 3, 2025 · NCT06683092A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 12 and older · All sexes · Updated Oct 1, 2025 · NCT06504589Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
- University of Kansas Medical Center, Kansas City
RecruitingPhase 2
Ages 12 and older · All sexes · Updated May 2, 2025 · NCT06364176A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Nov 25, 2024 · NCT06526923From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.